Berberine vs Inositol: Clinical Comparison for PCOS, Insulin Resistance & Weight Loss
Comprehensive meta-analysis comparing Berberine HCl (AMPK activation) against Myo-Inositol & D-Chiro-Inositol (40:1 ratio) for glycemic control, ovarian morphology, and visceral adiposity in insulin-resistant populations.
Key Clinical Takeaways & Systematic Review Summary
Comprehensive meta-analysis comparing Berberine HCl (AMPK activation) against Myo-Inositol & D-Chiro-Inositol (40:1 ratio) for glycemic control, ovarian morphology, and visceral adiposity in insulin-resistant populations.
- Evidence Classification: Rigorously graded under standardized Cochrane & GRADE systematic review protocols.
- Literature Benchmark Dosage: Berberine: 1,000–1,500mg/day | Inositol: 4,000mg/day.
- Pharmacokinetic Timing: Berberine taken 15-20 min before carb meals; Inositol taken with morning & evening meals..
- Active Primary PubMed Reference: PMID 30552728 (European Journal of Obstetrics & Gynecology and Reproductive Biology).
Participate in Paid Clinical Research Studies ($750–$2,200 Stipends)
Accredited medical research centers are actively enrolling qualified participants for metabolic health, incretin therapy, and longevity studies. All physician evaluations, lab panels, and investigational compounds are provided at zero cost.
Check Clinical Trial Match Eligibility →Interactive Clinical Calculators & Drug Interaction Checkers
Calculate individualized body-weight dosages, check contraindications against prescription medications, and analyze 24-hour synergy schedules using our free interactive tool suite: